SignalFDA/Bio

Regeneron Pharmaceuticals (REGN) Wins FDA Approval For Pasatru In Adult FOP

FDA approval catalyst for REGN's Pasatru in adult FOP drives high biotech relevance.

What changed

FDA approval catalyst for REGN's Pasatru in adult FOP drives high biotech relevance.

Why it matters

FDA approval catalyst for REGN's Pasatru in adult FOP drives high biotech relevance. — impact context not separately stored; see What changed.

Sources